Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: IEEE EMBS Int Conf Biomed Health Inform. 2016 Feb;2016:577–580. doi: 10.1109/BHI.2016.7455963

Table 1. Datasets and Prediction Endpoints for Renal, Ovarian, and Pancreatic Cancer.

Cancer Grade Patient Survival
Renal Cancer Training Validation Training Validation
Grade 1 or 2 95 94 Known Survival <5 Years 62 61
Grade 3 or 4 115 114 Known Survival >= 5 Years 49 48

Total Samples 210 208 Total Samples 111 109

Ovarian Cancer Training Validation Training Validation
Grade 1 or 2 14 14 Known Survival <5 Years 63 62
Grade 3 or 4 111 111 Known Survival >= 5 Years 18 17

Total Samples 125 125 Total Samples 81 79